strong result outlook given
aggreg abt result ahead expect nearli
revenu segment beat expect gross margin higher
sg expens off-set top-lin beat ep match forecast
perhap importantli abt outlook came street
expect back stronger revenu outlook organ
growth model outlin recent rate chang
note quarterli preview expect strong print/outlook long-
term ep upsid possibl part due tax reform inde dynam
pan believ mani arrow abt quiver
feel littl risk execut share may uptick quarterli
beat today see share pretti fairli valu
segment result solid across board revenu standout
quarter includ solid ou diabet result driven libr
momentum better aler revenu accret model
nice uptick structur heart oper growth ww
regain good portion lost mri pacemak share
confid dynam persist close
product gap side notabl emerg market growth
perform better quarter double-digit growth china
libr custom addit encourag management avoid
commit exact guidanc libr revenu co
reiter comfort previous discuss rang
expect launch reportedli strong ou co see
upward new custom per quarter mostli new cgm
user lesser extent convers
valuat maintain neutral rate risk page
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
report revenu forecast
establish drove slight beat benefit broad-bas
perform sever countri includ china asia latin america
nutrit result in-lin growth balanc pediatr
adult busi medic devic outperform estim better
result ou diabet structur heart portico continu grow
nice albeit strong base offset lighter electrophysiolog
ep result note go forward ep result trend
better mri-saf platform ramp confirm boost ep revenu
line final diagnost revenu post meaning beat
quarter aler result come vs forecast
gross margin came bp model sg expens margin
wors ebit margin weaker
forecast adj ep in-lin forecast
make number chang estim first rais revenu
estim reflect posit outlook ou diabet
diagnost alin greater revenu contribut aler second
also updat forecast stronger euro third
adjust below-the-lin ebit item net interest expens recent
debt repay incom fourth trim oper margin
go forward mainli account higher sg expens final lower
actualsbtig estimate variancetot incom net bpssg spend bpsr spend bpsebit bpstax bpssourc btig estim compani filingsvari
adjust tax rate match compani new outlook post tax
new revenu estim new
adj ep forecast
abbott rate neutral share appreci last year
strong new product launch expect although like
product think upsid investor expect decreas feel
target multipl ntm earn appropri mirror histor
rang last year appli estim yield
enough upsid buy rate btig provid price target
neutral-r stock risk rate includ multipl expans
fall favor fda regulatori agenc product delay failur
execut merger synergi
net ep gross bpsadj ebit bpssourc btig estim compani filingsnewold changentm johnsonjnjsel nestlenesn-chnot novartisnvsnot rocherhhbynot thermo fishertmobuy danaherdhrnot strykersyknot danonebn-frnot bdxnot boston scientificbsxbuy baxterbaxnot zimmerzmhnot dentsplyxraynot sourc factset data btig estimatespr yieldp/ ex-amortcompanytickerr ptpricemarket cap
abbott incom statement sale ex oper interest incom incom tax expens net ep methodology/abt share net incom ep incl disc marginsgross expensescog oper expens ep btig estim compani report
abbott segment y/i y/i y/i y/i y/i medic devic report pre-acqestablish pharmaceuticalkey emerg market y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth laboratori y/i laboratori y/i growth laboratori y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth diagnost y/i diagnost y/i growth diagnost y/i growthy/i growth oper adj aleretot y/i y/i growth y/i growth oper adj btig estim
abbott segment devicesrhythm manag y/i manag y/i growth manag y/i growth y/i y/i growth y/i growth failur y/i failur y/i growth failur y/i growth y/i y/i growth y/i growth heart y/i heart y/i growth heart y/i growth y/i y/i growth y/i growth y/i y/i growth y/i growth devic y/i devic y/i growth devic y/i growth totaltot report segment us y/i report segment y/i report segment ww y/i btig estim compani adjust stj acquisit optic divestitur
btig cover compani mention report
appendix analyst certif import disclosur
